Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-28

Clinical Trial Update: Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial [Phase 2]

View source ↗

Summary

A Phase 2 active-comparator trial at the University of Iowa is evaluating psilocybin versus ketamine for treating alcohol use disorder, with recruitment ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Psilocybin (psilocybin)

Snippet

Sponsor: University of Iowa | Conditions: Alcohol Use Disorder, Alcohol Dependence | Phase 2 | Status: RECRUITING